Actual Medicinal Product (AMP) Ationdo SR 150mg tablets (Grunenthal Ltd)

Stability Information

(Some stability information inherited from generic)

Stability
compatible logo Medicines suitable for use in MCAs, although use is likely to be off-label.  Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or consider up to 8 weeks if the MCA is airtight (sealed).  Consider the risk to the individual from potency loss or dose variability, particularly with unsealed devices.  Monitor for any changes in therapeutic effect or increased adverse effects after MCA initiation.
Notes

No special storage conditions required.

Provenance

This compatibility recommendation is derived from Palexia SR tablets (Grunenthal Ltd).

Generic
Tapentadol
Formulation
Tapentadol 150mg modified-release tablets
  • Tapentadol
    • Tapentadol 150mg modified-release tablets

      • Ationdo SR 150mg tablets (Grunenthal Ltd)